Battiwalla, Minoo, MD

BMT Program Physician

Department of Medicine
Roswell Park Cancer Institute

Dr. Minoo Battiwalla joined the faculty of Roswell Park Cancer Institute in 2003. Dr. Battiwalla comes to RPCI from the National Institutes of Health, where he completed fellowships in Hematology, Medical Oncology and BMT. He earned his Medical degree at the Medical College, Calcutta, India, in 1994, and completed residency training in Internal Medicine at the University Hospital at Stony Brook, NY, in 1999. He also earned a Master's degree in Clinical Research from the Duke University School of Medicine.

Dr. Battiwalla's research interests include malignant hematology and stem cell transplantation, with a specific focus on the effects of the immune system in leukemia and myelodysplastic syndromes and the development of approaches to reducing the toxicity of stem cell transplantation.

Dr. Battiwalla is a Diplomate in the American Board of Internal Medicine and the subspecialty Boards of Oncology and Hematology. He is a member of the American Society of Hematology, American Society of Blood and Marrow Transplantation and the American College of Physicians.

Dr. Battiwalla has authored or co-authored several journal articles, abstracts and book chapters.

Selected Publications

Leflunomide failure to control recurrent cytomegalovirus infection in the setting of renal failure after allogeneic stem cell transplantation. M. Battiwalla, P. Paplham, N.G. Almyroudis, A. McCarthy, A. Abdelhalim, A. Elefante, P. Smith, J. Becker, P.L. McCarthy, B.H. Segal. Transpl Infect Dis 2007: 9: 28-32.

Prevention and early treatment of invasive fungal infection in patients with cancer and neutropenia and in stem cell transplant recipients in the era of newer broad-spectrum antifungal agents and diagnostic adjuncts. Segal, B.H., Almyroudis, N.G., Battiwalla, M., Herbrecht, R., Perfect, J.R., Walsh, T.J. & Wingard, J.R. Clin Infect Dis. 2007;44:402-409.

Long-term stability of a patient-convenient 1 mg/ml suspension of tacrolimus for accurate maintenance of stable therapeutic levels. Elefante A, Muindi J, West K, Dunford L, Abel S, Paplham P, Brown K, Hahn T, Padmanabhan S, Battiwalla M, McCarthy PL. Bone Marrow Transplant. 2006 Apr;37(8):781-4. Bone Marrow Transplantation (2006), 1–4.

Human Leukocyte Antigen (HLA) DR15 is Associated With Reduced Incidence Of Acute GVHD in HLA-matched Allogeneic Transplants But Does Not Impact Survival. Battiwalla M, Theresa Hahn, Marija Radovich, Hilary Roy, Afrin Wahab, Eileen Duman, Rajinder Bajwa, Swaminathan Padmanabhan, Joanne Becker, Philip L McCarthy, Jr. Blood. 1 March 2006 Volume 107, No. 5.

Immunotherapy for Fungal Infections. Segal BH, Kwon-Chung J, Walsh TJ, Klein BS, Battiwalla M, Almyroudis NG, Holland SM, and Romani L. Clin. Infectious Diseases. 42: 507-15, 2006.

Dapsone-induced methemoglobinemia after hematopoietic stem cell transplantation. Dunford LM, Roy DM, Hahn TE, Padmanabhan S, Segal BH, Almyroudis N, McCarthy PL Jr., Battiwalla M. Biol Blood Marrow Transplant. 2006;12:241-242.

Simultaneous Presentation Of Acute Monoblastic Leukemia And Mantle Cell Lymphoma: Case Report And Review Of The Literature. Attaphol Pawarode, Maria R. Baer, Swami Padmanabhan, Paul K. Wallace, Maurice Barcos, Sheila N.J. Sait, AnneMarie W. Block, Meir Wetzler, Minoo Battiwalla.Leukemia and Lymphoma. December 2005; 46(12): 1813 – 1818.

Long Term Oral Beclomethasone Dipropionate Use For The Treatment Of Chronic Gastrointestinal Graft-versus-host disease. Renuka V. Iyer, Theresa Hahn, Hilary N. Roy, Minoo Battiwalla, Mary Cooper, Barbara Anderson, Pam Paplham, Barbara Bambach, Brahm H. Segal, Philip L. McCarthy, Jr. Biol Blood Marrow Transplant. 2005 Aug;11(8):587-92.

T-cell responses against the Cytomegalovirus proteins pp65 and IE1. Bettinotti M, Solomon S, Battiwalla M, Hensel N, Ghazarian K, Stroncek D, Barrett J. Human Immunology. Volume 64, Issue 10, Supplement 1, October 2003, Page S73.

HLA-DR4 Predicts Hematological Response To Cyclosporine In T-Large Granular Lymphocyte (T-LGL) Lymphoproliferative Disorders. Battiwalla M, Sauntharajah Y, Nakamura R, Melenhorst J, Wisch L, Molldrem J, Barrett J. British Journal of Hematology 2003 Nov;123(3): 449-53.

Persisting posttransplantation cytomegalovirus antigenemia correlates with poor lymphocyte proliferation to cytomegalovirus antigen and predicts for increased late relapse and treatment failure. Nakamura R, Battiwalla M, Solomon S, Follmann D, Chakrabarti S, Cortez K, Hensel N, Childs R, Barrett J. Biology of Blood and Marrow Transplantation 2004 Jan;10(1): 49-57.

Emerging therapeutic strategies in myelodysplasia. Barrett J, Battiwalla M. Current Hematology Reports May 2003 Vol 2 (3) 193-201.

Extra-ocular muscle palsy from metastatic prostate cancer. Leonard G, Battiwalla M, Stockle J, Harris R, Monahan B, Grem J. Lancet Oncology. 2003 Jun; 4(6):358.

High-dose acyclovir and pre-emptive ganciclovir to prevent cytomegalovirus disease in myeloablative and non-myeloablative allogeneic stem cell transplantation. Nakamura R, Cortez K, Solomon S, Battiwalla M, Gill V, Hensel N, Childs R, Barrett J. Bone Marrow Transplant Aug. 2002 Vol. 30(4) 235-242.

Allogeneic transplantation using non-myeloablative transplant regimens. Battiwalla M, Barrett J. Best Practice & Research Clinical Haematology Dec. 2001 Vol. 14, No. 4. 2001.

Antibody induced coagulopathy from bovine thrombin use during partial nephrectomy.  Pavlovich CP, Battiwalla M, Rick ME, Walther MM. J Urol. 2001 May; 165(5): 1617.

Gene therapy strategies for Leukemia. Braun SE, Chen K, Battiwalla M, Cornetta K. Molecular Medicine Today Vol.3, Jan 1997, 39-46.

BOOK CHAPTERS

Battiwalla, M. and Young NS. "Myelodysplastic Syndromes".  Bethesda Handbook of Clinical Hematology. Editor Griffin P. Rodgers and Neal S. Young. Lippincott, Williams and Wilkins, 2004.